Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 57179-35-8 | MDL No. : | MFCD16998726 |
Formula : | C8H8O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FGQOOHJZONJGDT-UHFFFAOYSA-N |
M.W : | 152.15 | Pubchem ID : | 5314561 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 40.34 |
TPSA : | 46.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.96 cm/s |
Log Po/w (iLOGP) : | 1.38 |
Log Po/w (XLOGP3) : | 1.78 |
Log Po/w (WLOGP) : | 1.21 |
Log Po/w (MLOGP) : | 0.51 |
Log Po/w (SILICOS-IT) : | 1.49 |
Consensus Log Po/w : | 1.28 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.18 |
Solubility : | 1.01 mg/ml ; 0.00666 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.38 |
Solubility : | 0.641 mg/ml ; 0.00421 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.88 |
Solubility : | 2.0 mg/ml ; 0.0132 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.17 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With formaldehyd; sodium thioethylate In N,N-dimethyl-formamide at 145℃; for 1 h; | To a 1.0-L three-neck flask was added sodium ethanethiolate (80percent, 28.5 g, 271.0 mmol) and anhydrous DMF (225 mL). The mixture was heated to 145° C. for 1.5 hours. Then, 3,5-dimethoxy-benzaldehyde (15.0 g, 90.0 mmol) in anhydrous DMF (350 mL) was added over a period of 8 minutes. The reaction was kept at 145° C. for another 1 hour, then cooled to room temperature. Saturated sodium chloride solution (2.5 L) and formaline (37percent, 240 mL) together with acetic acid (500 mL) was added. The resulting solution was thoroughly extracted with ethyl acetate, the organic phase was dried with sodium sulfate, and the solvent was removed under vacuum. The crude compound was purified by column chromatography (silica gel 230-400 mesh; eluting with dichloromethane and ethyl acetate 7:1) to give 3-hydroxy-5-methoxy-benzaldehyde as a white solid. Yield: 12.0 g (88percent) |
70% | With sodium hydride In N,N-dimethyl-formamide; ethanethiol; mineral oil for 1 h; Inert atmosphere; Reflux | NaH (2.72 g, 71.4 mmol, 60percent in mineral oil) was taken in an oven-dried RB flask equipped with magnetic stir bar and anhydrous DMF (60 mL) was added. After cooling the solution at 0° C., ethanethiol (7 mL, 93.4 mmol) was slowly added via a syringe, once the evolution of H2 ceased, it was refluxed under N2 atmosphere for 1 h. Next, aldehyde E (3.84 g, 23.6 mmol) in DMF (90 mL) was added and the resulting solution was refluxed under N2 atmosphere for 1 h. The reaction mixture was then cooled and quenched by the addition of saturated aqueous NaCl (750 mL), 26percent formaline (75 mL), and acetic acid (140 mL). The reaction mixture was then thoroughly extracted with ethyl acetate, the organic layer was dried over Na2SO4 and concentrated under vacuum to obtain a crude dark syrup. The crude syrup was purified by gradient column chromatography using hexanes and ethyl acetate (100:1 to 1:1) to afford the desired aldehyde F as a yellow solid (70percent). [0099] 1H NMR (500 MHz, CDCl3): δ 9.84 (s, 1H, —CHO), 6.96 (d, J=2.5 Hz, 2H), 6.68 (t, J=2.1 Hz, 1H), 3.83 (s, 3H). [0100] 13C NMR (125 MHz, CDCl3): δ 192.8, 161.2, 158.6, 138.1, 109.2, 108.2, 106.0, 55.4 |
17.6% | With sodium hydride; ethanethiol In DMF (N,N-dimethyl-formamide) at 0 - 20℃; for 2.5 h; Heating / reflux | Example 16-1 Preparation for 3-hydroxy-5-methoxybenzaldehyde To a solution of 60percent sodium hydride (2.77g, 69.3mmol) in N,N-dimethylformamide (50ml) was gradually added at 0°C ethanethiol (7ml), and the solution was stirred at 0°C for 30 minutes, followed by refluxing under heating for 1 hour.. The mixture was cooled to room temperature, and thereto was added 3,5-dimethoxybenzaldehyde (3.84g, 23.1mmol) in N,N-dimethylformamide (90ml) and the mixture was refluxed under heating for 1 hour.. The mixture was cooled to room temperature, and thereto were added a saturated aqueous sodium chloride solution (700ml), 26percent aqueous formalin solution (70ml) and acetic acid (130ml) in the order.. The mixture was stirred, extracted with ethyl acetate.. The organic layer was washed with water and an aqueous saturated sodium chloride solution in the order, and dried over anhydrous magnesium sulfate.. The solvent was removed under reduced pressure and the residue was purified with silica gel chromatography (hexane:ethyl acetate=2:1) to give the subject compound (2.68g, 17.6percent).1H NMR (CDCl3, 400 MHz) δ 9.88 (s, 1 H), 7.00 (m, 1 H), 6.96 (m, 1 H), 6.68 (t, 1 H, J = 2.3 Hz), 3.84 (s, 3 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | With potassium carbonate In N,N-dimethyl-formamide at -10℃; Inert atmosphere | To a stirredsuspension of 3,5-dihydroxybenzaldehyde, 12 (2.76 g,20.0 mmol) and K2CO3 (2.76 g, 20.0 mmol) in DMF(50 mL) was added methyl iodide (1.25 mL, 20.0 mmol)dropwise at −10 C under nitrogen atmosphere. The mixturewas stirred for 3 h at this temperature. After completion of thereaction, water (70 mL) was added. The mixture was thenextracted with ether (2 × 80 mL), the combined organic layerwas washed with brine (2 × 80 mL), dried over anhydrousNa2SO4, filtered and the filtrate was concentrated in vacuo.The crude residue was purified by column chromatography(EtOAc/hexane = 1/4) to yield the compound 17 (1.19 g,39percent) as white solid. Rf = 0.23 (EtOAc/hexane = 1/4); mp128–130 C; 1H NMR (300 MHz, CDCl3) δ 9.86 (1H, s),6.98 (1H, dd, J = 2.4, 1.5 Hz), 6.95 (1H, dd, J = 2.4,1.5 Hz), 6.67 (1H, t, J = 2.4 Hz), 5.79 (1H, s), 3.84 (3H, s);13C NMR (75 MHz, CDCl3) δ 191.8, 161.3, 157.2, 138.4,109.0, 108.1, 107.0, 55.7. |
39% | With potassium carbonate In N,N-dimethyl-formamide at -10℃; for 3 h; Inert atmosphere | To a suspension of 3,5-dihydroxybenzaldehyde (3,5-dihydroxybenzaldehyde, compound 12) (2.76 g, 20.0 mmol) and K2CO3 (2.76 g, 20.0 mmol) in DMF (50 mL) was added methyl iodide (1.25 mL, 20.0 mmol) in a nitrogen atmosphere, - 10°C. The reaction mixture was stirred at this temperature for three hours. After the reaction was completed, 70 ml of water was added. The reaction mixture was then extracted with ether (2 x 80 mL) and the combined organic layers were washed with brine (2 x 80 mL), dried over anhydrous Na2SO4,The filtrate was concentrated in vacuo. The crude compound was purified by column chromatography (EtOAc / hexane = 1/4) to obtain a white solid compound 17 (1.19 g, 39percent). |
29% | Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5 h; Stage #2: at 20℃; for 16 h; |
3-Hydroxy-5-methoxybenzaldehyde (240)A stirred solution of 3,5-dihydroxybenzaldehyde (1.0 g, 7.24 mmol) in DMF (20 mL) is treated with sodium hydride (319 mg, 8.0 mmol, 60percent dispersion in mineral EPO <DP n="361"/>oil) at O0C. After warming to RT and stirring 0.5 h, the reaction is treated with iodomethane (0.50 mL, 8.0 mmol) via syringe and stirred 16 h. It is then diluted with 1 M HCl (100 mL) and extracted into EtOAc (50 mL). The EtOAc phase is washed with 1 M HCl (50 mL), water (2 x 50 mL) and brine (50 mL), dried over Na2SO4 then the EtOAc removed in vacuo. The title compound is obtained after chromatography (gradient elution - 0-50percent EtOAc in heptane). Yield: 315 mg (29percent). |
29% | Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5 h; Stage #2: for 16 h; |
3-Hydroxy-5-methoxybenzaldehyde (240)A stirred solution of 3,5-dihydroxybenzaldehyde (1.0 g, 7.24 mmol) in DMF (20 mL) was treated with sodium hydride (319 mg, 8.0 mmol, 60percent dispersion in mineral oil) at 0°C. After warming to RT and stirring 0.5 h, the reaction was treated with iodomethane (0.50 mL, 8.0 mmol) via syringe and stirred 16 h. It was then diluted with 1 M HCl (100 mL) and extracted into EtOAc (50 mL). The EtOAc phase was washed with 1 M HCl (50 mL), water (2 x 50 mL) and brine (50 mL), dried over Na2SO4 then the EtOAc removed in vacuo. The title compound was obtained after chromatography (gradient elution - 0-50percent EtOAc in heptane). Yield: 315 mg (29percent). |
29% | Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5 h; Stage #2: for 16 h; |
3-Hydroxy-5-methoxybenzaldehyde (240); A stirred solution of 3,5-dihydroxybenzaldehyde (1.0 g, 7.24 mmol) in DMF (20 mL) is treated with sodium hydride (319 mg, 8.0 mmol, 60percent dispersion in mineral EPO <DP n="361"/>oil) at 0°C. After warming to RT and stirring 0.5 h, the reaction is treated with iodomethane (0.50 mL, 8.0 mmol) via syringe and stirred 16 h. It is then diluted with 1 M HCl (100 mL) and extracted into EtOAc (50 mL). The EtOAc phase is washed with 1 M HCl (50 mL), water (2 x 50 mL) and brine (50 mL), dried over Na2SO4 then the EtOAc removed in vacuo. The title compound is obtained after chromatography (gradient elution - 0-50percent EtOAc in heptane). Yield: 315 mg (29percent).. |
29% | Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5 h; Stage #2: for 16 h; |
Synthesis of Compound 394; 3-Hydroxy-5-methoxybenzaldehyde (240); A stirred solution of 3,5-dihydroxybenzaldehyde (1.0 g, 7.24 mmol) in DMF (20 mL) is treated with sodium hydride (319 mg, 8.0 mmol, 60percent dispersion in mineral EPO <DP n="361"/>oil) at 0°C. After warming to RT and stirring 0.5 h, the reaction is treated with iodomethane (0.50 mL, 8.0 mmol) via syringe and stirred 16 h. It is then diluted with 1 M HCl (100 mL) and extracted into EtOAc (50 mL). The EtOAc phase is washed with 1 M HCl (50 mL), water (2 x 50 mL) and brine (50 mL), dried over Na2SO4 then the EtOAc removed in vacuo. The title compound is obtained after chromatography (gradient elution - 0-50percent EtOAc in heptane). Yield: 315 mg (29percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25% | With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; for 0.5 h; | a) 3 Hydroxy-5-methoxybenzaldehyde Diethyl azodicarboxylate (1.5 mL, 9.53 mmol) was added to a solution of 1.14 g (8.26 mmol) of 3,5-dihydroxybenzaldehyde, 2.39 g (9.12 mmol) of triphenylphosphine, and 380 μL (9.4 mmol) of methanol in anhydrous tetrahydrofuran (20 mL) at 0 °C. The reaction mixture was stirred at ambient temperature for 30 min and quenched with 10percent aqueous citric acid. The reaction mixture was extracted into diethyl ether, dried (MgSO4), and purified by flash chromatography (dichloromethane / petroleum ether (2: 1 then 100: 0)) to give the title compound (309 mg, 25percent) as a gum. 1H-NMR (300 MHz, CDCl3) δ 9.82 (s, 1 H), 6.98 - 6.99 (m, 2 H), 6.94 - 6.96 (m, 1 H), 3.80 (s, 3 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | Stage #1: at 145℃; for 1.5 h; Stage #2: at 145℃; for 1.13333 h; |
Example 123 Preparation of 5,7-Dimethoxy-2-(3-methoxy-5-(2-(pyrrolidin-1-yl)ethoxy)phenyl)quinazolin-4(3H)-one To a 1.0-L three-neck flask was added sodium ethanethiolate (80percent, 28.5 g, 271.0 mmol) and anhydrous DMF (225 mL). The mixture was heated to 145° C. for 1.5 hours. Then, 3,5-dimethoxy-benzaldehyde (15.0 g, 90.0 mmol) in anhydrous DMF (350 mL) was added over a period of 8 minutes. The reaction was kept at 145° C. for another 1 hour, then cooled to room temperature. Saturated sodium chloride solution (2.5 L) and formaline (37percent, 240 mL) together with acetic acid (500 mL) was added. The resulting solution was thoroughly extracted with ethyl acetate, the organic phase was dried with sodium sulfate, and the solvent was removed under vacuum. The crude compound was purified by column chromatography (silica gel 230-400 mesh; eluting with dichloromethane and ethyl acetate 7:1) to give 3-hydroxy-5-methoxy-benzaldehyde as a white solid. Yield: 12.0 g (88percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25% | With triphenylphosphine In tetrahydrofuran; methanol; Petroleum ether | a 3-Hydroxy-5-methoxybenzaldehyde Diethyl azodicarboxylate (1.5 mL, 9.53 mmol) was added to a solution of 1.14 g (8.26 mmol) of 3,5-dihydroxybenzaldehyde, 2.39 g (9.12 mmol) of triphenylphosphine, and 380 μL (9.4 mmol) of methanol in anhydrous tetrahydrofuran (20 mL) at 0° C. The reaction mixture was stirred at ambient temperature for 30 min and quenched with 10percent aqueous citric acid. The reaction mixture was extracted into diethyl ether, dried (MgSO4), and purified by flash chromatography (dichloromethane/petroleum ether (2:1 then 100:0)) to give the title compound (309 mg, 25percent) as a gum. 1 H-NMR (300 MHz, CDCl3) δ 9.82 (s, 1 H), 6.98-6.99 (m, 2 H), 6.94-6.96 (m, 1 H), 3.80 (s, 3 H). |
[ 90674-26-3 ]
3-Methoxy-5-methylbenzaldehyde
Similarity: 0.97
[ 951800-15-0 ]
3-Ethoxy-5-hydroxybenzaldehyde
Similarity: 0.95
[ 19447-00-8 ]
4-Methoxy-2,6-dimethylbenzaldehyde
Similarity: 0.93
[ 90674-26-3 ]
3-Methoxy-5-methylbenzaldehyde
Similarity: 0.97
[ 951800-15-0 ]
3-Ethoxy-5-hydroxybenzaldehyde
Similarity: 0.95
[ 19447-00-8 ]
4-Methoxy-2,6-dimethylbenzaldehyde
Similarity: 0.93
[ 90674-26-3 ]
3-Methoxy-5-methylbenzaldehyde
Similarity: 0.97
[ 951800-15-0 ]
3-Ethoxy-5-hydroxybenzaldehyde
Similarity: 0.95
[ 19447-00-8 ]
4-Methoxy-2,6-dimethylbenzaldehyde
Similarity: 0.93